Morgan Stanley
DOCS icon

Morgan Stanley’s Doximity DOCS Stock Holding History

Morgan Stanley’s Portfolio DOCS Stock Details DOCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.1M Buy
2,194,749
+744,842
+51% +$23.2M ﹤0.01% 2072
2025
Q4 		$64.2M Buy
1,449,907
+129,608
+10% +$7.28M ﹤0.01% 1849
2025
Q3 		$96.6M Buy
1,320,299
+18,865
+1% +$1.23M 0.01% 1432
2025
Q2 		$79.8M Buy
1,301,434
+19,252
+2% +$1.07M 0.01% 1509
2025
Q1 		$74.4M Buy
1,282,182
+39,293
+3% +$2.48M 0.01% 1472
2024
Q4 		$66.4M Sell
1,242,889
-4,092,452
-77% -$200M ﹤0.01% 1580
2024
Q3 		$232M Sell
5,335,341
-1,587,229
-23% -$52.9M 0.02% 748
2024
Q2 		$194M Sell
6,922,570
-60,643
-0.9% -$1.6M 0.02% 820
2024
Q1 		$188M Sell
6,983,213
-7,057,065
-50% -$201M 0.02% 829
2023
Q4 		$394M Buy
14,040,278
+6,622,929
+89% +$156M 0.02% 774
2023
Q3 		$157M Sell
7,417,349
-3,963,076
-35% -$108M 0.02% 808
2023
Q2 		$387M Sell
11,380,425
-4,420,597
-28% -$147M 0.04% 448
2023
Q1 		$512M Buy
15,801,022
+398,287
+3% +$13.2M 0.05% 341
2022
Q4 		$517M Sell
15,402,735
-254,045
-2% -$7.76M 0.06% 333
2022
Q3 		$473M Sell
15,656,780
-314,118
-2% -$11.5M 0.06% 289
2022
Q2 		$556M Buy
15,970,898
+6,743,183
+73% +$265M 0.07% 258
2022
Q1 		$481M Sell
9,227,715
-845,437
-8% -$42.5M 0.06% 273
2021
Q4 		$505M Buy
10,073,152
+8,027,846
+393% +$523M 0.06% 288
2021
Q3 		$165M Buy
2,045,306
+1,030,417
+102% +$75.4M 0.02% 606
2021
Q2 		$59.1M Buy
+1,014,889
New +$57M 0.01% 1191

Other funds holding DOCS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley's DOCS Position: Q1 2026 in Review

Morgan Stanley increased its Doximity (DOCS) stake by 51% in Q1 2026, buying an estimated $23.2M and bringing the position to 2,194,749 shares worth $51.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2072.

Morgan Stanley first reported a position in DOCS in Q2 2021 and has held it in 20 quarters since. The position peaked at $556M in Q2 2022. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Morgan Stanley held 2,194,749 shares of Doximity worth $51.1M as of Q1 2026.
  • Morgan Stanley bought 744,842 Doximity shares in Q1 2026, an estimated $23.2M.
  • Doximity made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2072 holding.
  • Morgan Stanley first reported a position in Doximity in Q2 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Doximity position peaked at $556M in Q2 2022.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.